John Liu, MD, PhD
Asst Professor in Residence
Radiation Oncology
School of Medicine

The Liu Lab at UCSF is an interdisciplinary basic and translational research group dedicated to advancing new treatments for malignant brain tumors and understanding mechanisms of treatment resistance. We develop and apply cutting-edge functional genomic approaches collaboratively to achieve this mission. In particular:

Show full bio (180 words) Hide full bio

1) Discovery of novel cancer targets using functional genomics. Advances in CRISPR/Cas9 technologies have enabled large-scale multiplexed genetic screening for novel therapeutic targets and genetic interaction mapping across many contexts. We use genome-wide CRISPR screens and in vivo perturb-seq to identify and characterize targets that render tumors more sensitive to treatment such as chemotherapy or radiation therapy.

2) Role of DNA damage response in radiation treatment resistance. The ability of cancer cells to repair DNA damage caused by radiation therapy is major barrier to effective treatments for patients with brain tumors. We are interested in targeting known and novel vulnerabilities in the DNA damage response to improve therapeutics against brain tumors such as adult and pediatric glioblastomas, among the deadliest primary brain tumors.

3) Epigenetic engineering as novel precision therapeutics for cancer Engineered CRISPR/Cas9 systems enable control of gene expression and epigenetic state in cells and tumors. We develop epigenetic editing strategies for in vivo applications in oncology to understand and exploit the role of epigenetics in tumor progression and treatment resistance.

Awards

Show all (6) Hide

  • Sontag Distinguished Scientist Award, University of California, San Francisco, 2025-2030
  • V Foundation Scholar Award, University of California, San Francisco, 2025-2028
  • Weill Neurohub Investigator, University of California, San Francisco, 2025-2027
  • The Sontag Foundation Conquer Cancer Young Investigator Award, University of California, San Francisco, 2022-2023
  • ABR Holman Pathway, University of California, San Francisco, 2020-2024
  • RSNA Roentgen Resident/Fellow Research Award, University of California, San Francisco, 2020-2024

Education & Training

Show all (5) Hide

  • Radiation Oncology Residency University of California, San Francisco 06/2024
  • Internal Medicine Prelim Kaiser Permanente 06/2020
  • MD Medicine University of California, San Francisco 06/2019
  • PhD Biomedical Sciences University of California, San Francisco 03/2017
  • AB Chemical and Physical Biology Harvard University 05/2011

Websites

Show all (2) Hide

Grants and Projects

Show all (1) Hide

Publications (36)

Top publication keywords:
CRISPR-Cas SystemsEpigenomicsGlioblastomaBrain NeoplasmsClustered Regularly Interspaced Short Palindromic RepeatsEpendymoglial CellsGenetic HeterogeneityLentivirusNeurilemmomaRNA, Long NoncodingGene EditingEpigenesis, GeneticGene Knockdown TechniquesEpendymomaProteasome Inhibitors

Show all (31 more) Hide